Gallic acid regulates immune response in a mouse model of rheumatoid arthritis

Abstract Introduction Previous studies revealed that gallic acid (GA) exerts anti‐inflammation and immuno‐regulatory properties. This study aims to explore the pharmacological activities of GA in collagen‐induced arthritis (CIA) mouse model. Methods Male DBA/1J mice were used to construct the CIA mo...

Full description

Bibliographic Details
Main Authors: Siqin Liu, Jiajia Li, Le‐heng Feng
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.782
_version_ 1797816615599865856
author Siqin Liu
Jiajia Li
Le‐heng Feng
author_facet Siqin Liu
Jiajia Li
Le‐heng Feng
author_sort Siqin Liu
collection DOAJ
description Abstract Introduction Previous studies revealed that gallic acid (GA) exerts anti‐inflammation and immuno‐regulatory properties. This study aims to explore the pharmacological activities of GA in collagen‐induced arthritis (CIA) mouse model. Methods Male DBA/1J mice were used to construct the CIA model. The mice were administrated with GA for 3 weeks. Clinical arthritis scores and hind paw volume were evaluated over the experimental period. qPCR and Western blot analysis were used to determine the levels of matrix metallopeptidases (MMPs) and cytokines. In addition, flow cytometry was used to measure the populations of Th17 and Treg cells. ELISAs were used to determine the cytokines in the serum and ankle joint tissues. Results Treatment of GA (40 and 80 mg/kg/d) reduced clinical arthritis scores and hind paw volume in the CIA mouse model. Besides, treatment of GA reduced the overexpression of MMPs and modulated the dysregulation of inflammation‐related cytokines. Flow cytometry showed that treatment of GA decreased the population of Th17 cells, and increased the population of Treg cells, as supported by treatment of GA regulated the Th17/Treg‐related cytokines. Conclusions GA attenuates symptoms in the CIA mouse model by anti‐inflammation and regulating Th17/Treg cell imbalance.
first_indexed 2024-03-13T08:41:16Z
format Article
id doaj.art-a185d8f2624a4d88871e975d45417572
institution Directory Open Access Journal
issn 2050-4527
language English
last_indexed 2024-03-13T08:41:16Z
publishDate 2023-02-01
publisher Wiley
record_format Article
series Immunity, Inflammation and Disease
spelling doaj.art-a185d8f2624a4d88871e975d454175722023-05-30T12:15:46ZengWileyImmunity, Inflammation and Disease2050-45272023-02-01112n/an/a10.1002/iid3.782Gallic acid regulates immune response in a mouse model of rheumatoid arthritisSiqin Liu0Jiajia Li1Le‐heng Feng2Department of Laboratory Daqing Oilfield General Hospital Daqing Heilongjiang ChinaDepartment of Laboratory Daqing Oilfield General Hospital Daqing Heilongjiang ChinaDepartment of Rheumatism, The First Hospital of Qiqihar Affiliated Qiqihar Hospital of Southern Medical University Qiqihar Heilongjiang ChinaAbstract Introduction Previous studies revealed that gallic acid (GA) exerts anti‐inflammation and immuno‐regulatory properties. This study aims to explore the pharmacological activities of GA in collagen‐induced arthritis (CIA) mouse model. Methods Male DBA/1J mice were used to construct the CIA model. The mice were administrated with GA for 3 weeks. Clinical arthritis scores and hind paw volume were evaluated over the experimental period. qPCR and Western blot analysis were used to determine the levels of matrix metallopeptidases (MMPs) and cytokines. In addition, flow cytometry was used to measure the populations of Th17 and Treg cells. ELISAs were used to determine the cytokines in the serum and ankle joint tissues. Results Treatment of GA (40 and 80 mg/kg/d) reduced clinical arthritis scores and hind paw volume in the CIA mouse model. Besides, treatment of GA reduced the overexpression of MMPs and modulated the dysregulation of inflammation‐related cytokines. Flow cytometry showed that treatment of GA decreased the population of Th17 cells, and increased the population of Treg cells, as supported by treatment of GA regulated the Th17/Treg‐related cytokines. Conclusions GA attenuates symptoms in the CIA mouse model by anti‐inflammation and regulating Th17/Treg cell imbalance.https://doi.org/10.1002/iid3.782collagen‐induced arthritisgallic acidinflammationTh17Treg
spellingShingle Siqin Liu
Jiajia Li
Le‐heng Feng
Gallic acid regulates immune response in a mouse model of rheumatoid arthritis
Immunity, Inflammation and Disease
collagen‐induced arthritis
gallic acid
inflammation
Th17
Treg
title Gallic acid regulates immune response in a mouse model of rheumatoid arthritis
title_full Gallic acid regulates immune response in a mouse model of rheumatoid arthritis
title_fullStr Gallic acid regulates immune response in a mouse model of rheumatoid arthritis
title_full_unstemmed Gallic acid regulates immune response in a mouse model of rheumatoid arthritis
title_short Gallic acid regulates immune response in a mouse model of rheumatoid arthritis
title_sort gallic acid regulates immune response in a mouse model of rheumatoid arthritis
topic collagen‐induced arthritis
gallic acid
inflammation
Th17
Treg
url https://doi.org/10.1002/iid3.782
work_keys_str_mv AT siqinliu gallicacidregulatesimmuneresponseinamousemodelofrheumatoidarthritis
AT jiajiali gallicacidregulatesimmuneresponseinamousemodelofrheumatoidarthritis
AT lehengfeng gallicacidregulatesimmuneresponseinamousemodelofrheumatoidarthritis